NDC 24979-002

Dexlansoprazole delayed release

Dexlansoprazole

Dexlansoprazole delayed release is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Twi Pharmaceuticals, Inc.. The primary component is Dexlansoprazole.

Product ID24979-002_80142b1d-6f72-41e5-bee3-064b6ec1e7dd
NDC24979-002
Product TypeHuman Prescription Drug
Proprietary NameDexlansoprazole delayed release
Generic NameDexlansoprazole
Dosage FormCapsule, Delayed Release
Route of AdministrationORAL
Marketing Start Date2022-12-01
Marketing CategoryANDA /
Application NumberANDA202666
Labeler NameTWI PHARMACEUTICALS, INC.
Substance NameDEXLANSOPRAZOLE
Active Ingredient Strength60 mg/1
Pharm ClassesProton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 24979-002-06

30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (24979-002-06)
Marketing Start Date2022-12-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Dexlansoprazole delayed release" or generic name "Dexlansoprazole"

NDCBrand NameGeneric Name
50090-4374Dexilantdexlansoprazole
55154-5154Dexilantdexlansoprazole
64764-171Dexilantdexlansoprazole
64764-175Dexilantdexlansoprazole
24979-001Dexlansoprazoledexlansoprazole
24979-002Dexlansoprazoledexlansoprazole
24979-703Dexlansoprazoledexlansoprazole
24979-704Dexlansoprazoledexlansoprazole
49884-148DexlansoprazoleDexlansoprazole
50090-5944Dexlansoprazoledexlansoprazole
50090-5956Dexlansoprazoledexlansoprazole

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.